• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

保加利亚慢性阻塞性肺疾病患者的合并症——患病率及其与严重程度和炎症的关联

Comorbidities of COPD in Bulgarian Patients - Prevalence and Association with Severity and Inflammation.

作者信息

Stratev Velin, Petkova Diana, Dimitrova Valentina, Petev Jordan

机构信息

Department of Pulmonary Diseases, Prof. Dr. Paraskev Stoyanov Medical University, Varna, Bulgaria.

Clinic of Pulmonary Diseases, St. Marina University Hospital, Varna, Bulgaria.

出版信息

Folia Med (Plovdiv). 2018 Mar 1;60(1):102-109. doi: 10.1515/folmed-2017-0078.

DOI:10.1515/folmed-2017-0078
PMID:29668450
Abstract

BACKGROUND

wis a disease with constantly rising economic and social burden; it is associated with multiple comorbidities which contribute to the disease severity.

AIM

To investigate the prevalence of co-morbidities in COPD patients and their association with the disease severity and CRP levels.

PATIENTS AND METHODS

We conducted a retrospective study among 338 COPD patients (mean age 65.2±7.6 years) with assessment of comorbidities, spirometry measurements and serum levels of CRP. In 183 patients we found metabolic syndrome (MS) according to IDF criteria.

RESULTS

We found prevalence of cardiovascular diseases (CVD) of 73.5% (hyper-tension 70.4%, CHF 47.4%, ishemic heart disease 37.5%, and cardiac arrhythmias 12.6%), with higher prevalence in patients with more severe disease. We found prevalence of type 2 diabetes of 21.1%, and 12.4% prevalence of bronchiectasis. In a subpopulation of the patients we found 48.1% prevalence of MS and the serum levels of CRP were significantly higher in patients with COPD and MS compared to those without the syndrome: 7.4 (3.14 - 11. 54) mg/ml vs 4.06 (2.64 - 6.93) mg/ml, p=0.006.

CONCLUSION

The present study suggests high prevalence of CVD comorbidities in COPD patients and association with the disease severity. Metabolic syndrome is a common comorbidity and is associated with increased inflammatory response.

摘要

背景

慢性阻塞性肺疾病(COPD)是一种经济和社会负担不断加重的疾病;它与多种合并症相关,这些合并症会加重疾病的严重程度。

目的

调查慢性阻塞性肺疾病(COPD)患者合并症的患病率及其与疾病严重程度和C反应蛋白(CRP)水平的关系。

患者与方法

我们对338例慢性阻塞性肺疾病(COPD)患者(平均年龄65.2±7.6岁)进行了一项回顾性研究,评估了合并症、肺功能测定和血清CRP水平。根据国际糖尿病联盟(IDF)标准,在183例患者中发现了代谢综合征(MS)。

结果

我们发现心血管疾病(CVD)的患病率为73.5%(高血压70.4%,心力衰竭47.4%,缺血性心脏病37.5%,心律失常12.6%),疾病越严重的患者患病率越高。我们发现2型糖尿病的患病率为21.1%,支气管扩张的患病率为12.4%。在患者亚组中,我们发现代谢综合征(MS)的患病率为48.1%,与无该综合征的慢性阻塞性肺疾病(COPD)患者相比,合并代谢综合征(MS)的慢性阻塞性肺疾病(COPD)患者血清CRP水平显著更高:7.4(3.14 - 11.54)mg/ml对4.06(2.64 - 6.93)mg/ml,p = 0.006。

结论

本研究表明慢性阻塞性肺疾病(COPD)患者心血管疾病合并症的患病率较高,且与疾病严重程度相关。代谢综合征是一种常见的合并症,与炎症反应增加有关。

相似文献

1
Comorbidities of COPD in Bulgarian Patients - Prevalence and Association with Severity and Inflammation.保加利亚慢性阻塞性肺疾病患者的合并症——患病率及其与严重程度和炎症的关联
Folia Med (Plovdiv). 2018 Mar 1;60(1):102-109. doi: 10.1515/folmed-2017-0078.
2
Metabolic Syndrome as a Factor Affecting Systemic Inflammation in Patients with Chronic Obstructive Pulmonary Disease.代谢综合征作为影响慢性阻塞性肺疾病患者全身炎症的一个因素。
Adv Exp Med Biol. 2017;1021:55-62. doi: 10.1007/5584_2017_28.
3
Prevalence of comorbidities in COPD patients by disease severity in a German population.德国人群中,COPD 患者的疾病严重程度与合并症的患病率。
Respir Med. 2017 Nov;132:132-138. doi: 10.1016/j.rmed.2017.10.007. Epub 2017 Oct 12.
4
Prevalence, associated factors, and clinical consequences of metabolic syndrome in chronic obstructive pulmonary disease patients: a 5-year prospective observational study.代谢综合征在慢性阻塞性肺疾病患者中的流行情况、相关因素及临床后果:一项为期 5 年的前瞻性观察研究。
Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231167342. doi: 10.1177/17534666231167342.
5
[Retrospective study on the prevalence of cardiovascular comorbidities in 4960 inpatients with chronic obstructive pulmonary disease in Beijing].[北京4960例慢性阻塞性肺疾病住院患者心血管合并症患病率的回顾性研究]
Zhonghua Liu Xing Bing Xue Za Zhi. 2011 Mar;32(3):297-301.
6
Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease.基于验证性客观测量和全身炎症的慢性阻塞性肺疾病患者的共病群。
Am J Respir Crit Care Med. 2013 Apr 1;187(7):728-35. doi: 10.1164/rccm.201209-1665OC.
7
Pattern of Cardiovascular Comorbidity in COPD in a Country with Low-smoking Prevalence: Results from Two-population-based Cohorts from Sweden.低吸烟率国家慢性阻塞性肺疾病患者的心血管合并症模式:来自瑞典两项基于人群队列的研究结果
COPD. 2018 Oct;15(5):454-463. doi: 10.1080/15412555.2018.1535580. Epub 2018 Nov 26.
8
Prevalence of comorbidities according to predominant phenotype and severity of chronic obstructive pulmonary disease.根据慢性阻塞性肺疾病的主要表型和严重程度划分的合并症患病率。
Int J Chron Obstruct Pulmon Dis. 2016 Sep 14;11:2229-2236. doi: 10.2147/COPD.S111724. eCollection 2016.
9
Evaluation of Markers of Inflammation and Oxidative Stress in COPD Patients with or without Cardiovascular Comorbidities.伴有或不伴有心血管合并症的慢性阻塞性肺疾病患者炎症和氧化应激标志物的评估
Heart Lung Circ. 2015 Aug;24(8):817-23. doi: 10.1016/j.hlc.2015.01.019. Epub 2015 Feb 20.
10
What is the impact of different spirometric criteria on the prevalence of spirometrically defined COPD and its comorbidities? Results from the population-based KORA study.不同肺量计标准对肺量计定义的慢性阻塞性肺疾病(COPD)及其合并症患病率有何影响?基于人群的德国健康访谈与检查调查(KORA)研究结果
Int J Chron Obstruct Pulmon Dis. 2016 Aug 16;11:1881-94. doi: 10.2147/COPD.S104529. eCollection 2016.

引用本文的文献

1
Influence of comorbidities in long-term survival of chronic obstructive pulmonary disease patients.合并症对慢性阻塞性肺疾病患者长期生存的影响。
J Thorac Dis. 2019 Apr;11(4):1379-1386. doi: 10.21037/jtd.2019.03.78.